FDA to Review Saxagliptin for Possible Heart Failure Risk More to come in next week's issue.
FDA to Review Saxagliptin for Possible Heart Failure Risk Feb 14, 20141,667 views Share Facebook Twitter LinkedIn FDA to Review Saxagliptin for Possible Heart Failure Risk More to come in next week’s issue.